Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa

Malaria has been hypothesized as a factor that may have reduced the severity of the COVID-19 pandemic in sub-Saharan Africa. To evaluate the effect of recent malaria on COVID-19 we assessed a subgroup of individuals participating in a longitudinal cohort COVID-19 serosurvey that were also undergoing...

Full description

Bibliographic Details
Main Authors: John Woodford, Issaka Sagara, Halimatou Diawara, Mahamadoun Hamady Assadou, Abdoulaye Katile, Oumar Attaher, Djibrilla Issiaka, Gaoussou Santara, Ibrahim H. Soumbounou, Seydou Traore, Moussa Traore, Oumar M. Dicko, Sidi Mohamed Niambele, Almahamoudou Mahamar, Bourama Kamate, Bayaya Haidara, Kourane Sissoko, Seydou Sankare, Sadio dite Koni Diarra, Amatigue Zeguime, Justin Y. A. Doritchamou, Irfan Zaidi, Alassane Dicko, Patrick E. Duffy
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
COVID-19
malaria
falciparum
serology
severity
West Africa
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.959697/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.959697/full

Similar Items